Portfolio (Quarterly)
Guide ↗
Seven Fleet Capital Management LP
· CIK 0002092021| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | — | ASCENDIS PHARMA A/S | — | 5,670.0 | $1.2M | 0.82% | NEW | — | $213.24 | — |
| 22 | FOLD | AMICUS THERAPEUTICS INC | Healthcare | 82,500.0 | $1.2M | 0.80% | NEW | — | $14.24 | +1.8% |
| 23 | PCVX | VAXCYTE INC | Healthcare | 25,365.0 | $1.2M | 0.79% | NEW | — | $46.14 | +16.0% |
| 24 | — | AVALO THERAPEUTICS INC | — | 63,343.0 | $1.2M | 0.78% | NEW | — | $18.16 | — |
| 25 | — | INHIBIKASE THERAPEUTICS INC | — | 533,648.0 | $1.1M | 0.74% | NEW | — | $2.05 | — |
| 26 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 1,860.0 | $1.1M | 0.73% | NEW | — | $582.34 | -7.3% |
| 27 | GERN | GERON CORP | Healthcare | 777,880.0 | $1.0M | 0.69% | NEW | — | $1.32 | +6.1% |
| 28 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 4,000.0 | $986K | 0.67% | NEW | — | $246.54 | +28.3% |
| 29 | LONA | ATHIRA PHARMA INC | Healthcare | 127,951.0 | $969K | 0.66% | NEW | — | $7.57 | +50.2% |
| 30 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 167,223.0 | $920K | 0.62% | NEW | — | $5.50 | +14.5% |
| 31 | SLN | SILENCE THERAPEUTICS PLC | Healthcare | 147,600.0 | $897K | 0.61% | NEW | — | $6.08 | +17.3% |
| 32 | — | ZURA BIO LTD | — | 166,500.0 | $872K | 0.59% | NEW | — | $5.24 | — |
| 33 | AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | 31,738.0 | $864K | 0.58% | NEW | — | $27.22 | +3.5% |
| 34 | CELC | CELCUITY INC | Healthcare | 8,338.0 | $832K | 0.56% | NEW | — | $99.74 | +38.0% |
| 35 | — | PRAXIS PRECISION MEDICINES I | — | 2,700.0 | $796K | 0.54% | NEW | — | $294.74 | — |
| 36 | KALV | KALVISTA PHARMACEUTICALS INC | Healthcare | 48,412.0 | $782K | 0.53% | NEW | — | $16.15 | +65.7% |
| 37 | — | PALISADE BIO INC | — | 327,500.0 | $770K | 0.52% | NEW | — | $2.35 | — |
| 38 | RLMD | RELMADA THERAPEUTICS INC | Healthcare | 154,109.0 | $744K | 0.50% | NEW | — | $4.83 | +53.6% |
| 39 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 8,000.0 | $699K | 0.47% | NEW | — | $87.34 | +20.8% |
| 40 | — | CIDARA THERAPEUTICS INC | — | 3,026.0 | $668K | 0.45% | NEW | — | $220.89 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%